Zacks Small Cap Research provides equity research on #smallcap and #microcap firms. https://xitter.cf/t.co/W18in20Snh

Chicago IL
Joined October 2010
$IXRRF: Ionic Rare Earths’ Technology and Significant Industry Tailwinds Support US$1.00 Price Target #criticalminerals #rareearthoxides #smallcaps #sustainabletechnology buff.ly/uWMm4EC
148
$SVTNF $LSTR.V Initiating Coverage of @LodestarMetals: Modest Footprint, Big Neighbours: Gold Run Maiden Drilling Confirms Multi-Style Gold-Silver System in Nevada buff.ly/dObN8mQ
161
$APVO: Mipletamig Combination Therapy Leads to 21% Stem Cell Transplantation Rate buff.ly/q14Crbt by @DavidBautz
196
$YOUL: Youlife Group Reports Strong 1st Half 2026 Results buff.ly/bxo4vx7
188
$HOVR: Advancing the Cavorite X7 Despite eVTOL Industry Turbulence #HybridFlight #AerospaceFuture #HorizonAircraftStock buff.ly/u7Gx7RZ
1
2
201
$NNUP: Building a Platform in Specialty Materials. Initiating Coverage of @NNUP_IR with a Valuation Target of $2.50. buff.ly/b20U3aE
277
$ICU @SeaStarMedical QUELIMMUNE® Demonstrates Statistically Significant Survival Benefit in SAVE Registry Patients buff.ly/HfgzeyS by @DavidBautz
298
$SNES @SenesTech Positive Takeaways of Virtual Meeting & of Longtime Institutional Shareholder Increased Stake buff.ly/V7hJsAR
1
301
$TRX $TRX.TO: @TRXGoldCorp Record Q4 Caps Fiscal 2026 at Top of Guidance; Drilling Ramp-Up Sets Stage for Expansion buff.ly/XXvHqHn
1
2
310
Zacks SCR retweeted
No Botox biosimilar has been approved since Botox launched in 1989. $AEON is developing ABP-450 to change that, with FDA studies expected in 2027. Our take in 60 seconds: buff.ly/qqOtKt5 #biotech #smallcapstocks #biosimilars
1
2
769